v3.24.2.u1
Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
Total
At The Market Offering
Private Placement
2026 Notes
2024 Securities Purchase Agreement
2026 Warrants
Common Stock
Common Stock
At The Market Offering
Common Stock
Private Placement
Common Stock
2026 Notes
Common Stock
2024 Securities Purchase Agreement
Common Stock
2026 Warrants
Additional Paid-in Capital
Additional Paid-in Capital
At The Market Offering
 [1]
Additional Paid-in Capital
Private Placement
 [1]
Additional Paid-in Capital
2026 Notes
 [3]
Additional Paid-in Capital
2024 Securities Purchase Agreement
 [3]
Additional Paid-in Capital
2026 Warrants
 [3]
Accumulated Deficit
Common stock, beginning balance (in shares) at Dec. 31, 2022 [1]             8,280,268                        
Beginning balance at Dec. 31, 2022 $ 108,586,931           $ 8,280 [1]           $ 736,227,713 [1]           $ (627,649,062)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Common stock issued (in shares) [1]               1,934,207 5,817                    
Common stock issued   $ 40,291,607 $ 200,000         $ 1,934 [1] $ 6 [1]         $ 40,289,673 $ 199,994        
Stock options and vesting of restricted shares (in shares) [1],[2]             40,766                        
Stock options and vesting of restricted shares [2] (475,589)           $ 41 [1]           (475,630) [1]            
Stock-based compensation 6,801,485                       6,801,485 [1]            
Net loss (48,016,713)                                   (48,016,713)
Common stock, ending balance (in shares) at Jun. 30, 2023 [1]             10,261,058                        
Ending balance at Jun. 30, 2023 107,387,721           $ 10,261 [1]           783,043,235 [1]           (675,665,775)
Common stock, beginning balance (in shares) at Mar. 31, 2023 [1]             9,029,035                        
Beginning balance at Mar. 31, 2023 104,820,548           $ 9,029 [1]           757,459,618 [1]           (652,648,099)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Common stock issued (in shares) [1]               1,214,968 5,817                    
Common stock issued   $ 21,699,420 $ 200,000         $ 1,215 [1] $ 6 [1]         $ 21,698,205 $ 199,994        
Stock options and vesting of restricted shares (in shares) [1],[2]             11,238                        
Stock options and vesting of restricted shares [2] (91,667)           $ 11 [1]           (91,678) [1]            
Stock-based compensation 3,777,096                       3,777,096 [1]            
Net loss (23,017,676)                                   (23,017,676)
Common stock, ending balance (in shares) at Jun. 30, 2023 [1]             10,261,058                        
Ending balance at Jun. 30, 2023 $ 107,387,721           $ 10,261 [1]           783,043,235 [1]           (675,665,775)
Common stock, beginning balance (in shares) at Dec. 31, 2023 14,299,042           14,299,042 [3]                        
Beginning balance at Dec. 31, 2023 $ 83,112,171           $ 14,299 [3]           834,666,123 [3]           (751,568,251)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Common stock issued (in shares) [3]             490,445                        
Common stock issued 1,242,649           $ 490 [3]           1,242,159 [3]            
Common stock issued, convertible securities (in shares) [3]                     4,949,646 425,000              
Common stock issued, convertible securities         $ 17,910,517 $ 2,847,500         $ 4,951 [3] $ 425 [3]         $ 17,905,566 $ 2,847,075  
Issuance of common stock under ELOC Purchase Agreement (in shares) [3]                   600,000                  
Issuance of common stock under ELOC Purchase Agreement       $ 3,124,000           $ 600 [3]           $ 3,123,400      
Stock options and vesting of restricted shares (in shares) [2],[3]             101,992                        
Stock options and vesting of restricted shares [2] (168,282)           $ 102 [3]           (168,384) [3]            
Stock-based compensation 6,044,520                       6,044,520 [3]            
Treasury Stock (in shares) [3]             (128,034)                        
Treasury Stock (332)           $ (129) [3]           (203) [3]            
Net loss $ (55,475,786)                                   (55,475,786)
Common stock, ending balance (in shares) at Jun. 30, 2024 20,738,091           20,738,091 [3]                        
Ending balance at Jun. 30, 2024 $ 58,636,957           $ 20,738 [3]           865,660,256 [3]           (807,044,037)
Common stock, beginning balance (in shares) at Mar. 31, 2024 [3]             16,539,599                        
Beginning balance at Mar. 31, 2024 67,423,772           $ 16,540 [3]           848,131,270 [3]           (780,724,038)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                                      
Common stock issued, convertible securities (in shares) [3]                     4,285,671                
Common stock issued, convertible securities         $ 14,642,070           $ 4,286 [3]           $ 14,637,784    
Stock options and vesting of restricted shares (in shares) [2],[3]             40,854                        
Stock options and vesting of restricted shares [2] (4,766)           $ 41 [3]           (4,807) [3]            
Stock-based compensation 2,896,212                       2,896,212 [3]            
Treasury Stock (in shares) [3]             (128,033)                        
Treasury Stock (332)           $ (129) [3]           (203) [3]            
Net loss $ (26,319,999)                                   (26,319,999)
Common stock, ending balance (in shares) at Jun. 30, 2024 20,738,091           20,738,091 [3]                        
Ending balance at Jun. 30, 2024 $ 58,636,957           $ 20,738 [3]           $ 865,660,256 [3]           $ (807,044,037)
[1] Prior periods presented have been adjusted to reflect the 1-for-20 reverse stock split which was effective on June 17, 2024. Additional information regarding the reverse stock split may be found in Note 1 Summary of Business and Significant Accounting Principles.
[2] Net of tax payments related to shares withheld for option exercises and vested stock.
[3] Prior periods presented have been adjusted to reflect the 1-for-20 reverse stock split which was effective on June 17, 2024. Additional information regarding the reverse stock split may be found in Note 1 Summary of Business and Significant Accounting Principles.